Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Shin (Seoul, Republic of Korea). Interplaying between Gamma-H2AX and autophagy in A549 cells treated with cisplatin and etoposide. 4860

Member's Comments

No comment yet.

Related content which might interest you: 2-Deoxy-glucose synergizes with Cisplatin and Pemetrexed chemotherapeutics to reduce cell migration of mesothelioma cells Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Generating senescent airway epithelial cell populations using low-concentration doxorubicin or etoposide Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 First line treatment with gemcitabine plus cisplatine in non-small cell lung cancer: a comparison with etoposide plus cisplatin Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005 Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 A comparison between the toxic side effects of adriamycin, cyclophosphamide, and etoposide (ACE) and carboplatin with etoposide (CbE) in the treatment of small cell lung cancer (SCLC) Source: Eur Respir J 2003; 22: Suppl. 45, 65s Year: 2003 Autophagy induction by low dose cisplatin; the role of p53 in autophagy Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012 Cisplatin and docetaxel induction chemotherapy results Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005 Non-small cell lung cancer treatment: chemotherapy combination gemcitabine – cisplatin – paclitaxel Source: Eur Respir J 2004; 24: Suppl. 48, 302s Year: 2004 Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifalpha destabilization Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Triptolide enhances radiosensitivity of lung cancer cells via G2/M arrest and autophage Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 microRNA-155 negatively regulates Apaf-1 and enhance sensitivity of A549 to cisplatin Source: Annual Congress 2012 - New aspects of lung cancer biology Year: 2012 Pegylated liposomal doxorubicin compared with traditional doxorubicin in combination chemo-radiotherapy for small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002 The effectiveness of vinorelbine plus cisplatin versus gemcitabine plus cisplatin in local advanced non small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006 Alpha1-antitrypsin inhibits staurosporine-induced apoptosis of NSCLC cells Source: Virtual Congress 2020 – Biological mechanisms of lung cancer Year: 2020 Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011 Effects of 2-Deoxy-glucose (2DG) with cisplatin and pemetrexed in mesothelioma cell mediated collagen gel contraction. Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding Year: 2019 Sequential monochemotherapy: vepesid (VP16) and carboplatin (CBDCA) in the treatment of elderly patients with small cell lung cancer (SCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001 Autophagy induces cytoprotection in cisplatin-treated lung cancer cells Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Prx1 provides resistance to docetaxel-induced apoptosis in lung cancer cells Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010